# XYZAL
> **NDA022064** · New Drug Application · Sponsor: CHATTEM SANOFI · Approved 2007-05-25
## Drug
- **FDA Application Number:** NDA022064
- **Application type:** New Drug Application
- **Brand name:** XYZAL
- **Generic name:** LEVOCETIRIZINE DIHYDROCHLORIDE
- **Active ingredients:** LEVOCETIRIZINE DIHYDROCHLORIDE
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Discontinued
- **Sponsor:** CHATTEM SANOFI
- **Manufacturer:** Chattem, Inc.
- **First approval:** 2007-05-25
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=022064)
---
*AI Analytics · CC0 1.0*